Today’s biggest winners and losers in the stock market.

On this episode of Stock Movers:

-Abercrombie & Fitch (ANF) shares fell as much as 9.4%, the most intraday since Jan. 12, after the apparel retailer’s forecast for first quarter net sales growth and profits trailed the consensus estimates. Fourth quarter comparable sales performance also missed expectations, with Hollister growth failing to reach expectations.

-Wix (WIX) shares rose as analysts pointed to signs of positive momentum, especially at its AI-powered platform Base44. However, they also noted that the results were mixed and flag that investments being made by the company will weigh on margins.

- Moderna (MRNA) agreed to pay $950 million to settle litigation related to the delivery technology behind its Covid shot, removing a looming financial risk for the struggling vaccine maker. The company has settled all litigation worldwide with Arbutus Biopharma Corp. and Genevant Sciences GmbH over its existing and future vaccines, with no future royalties owed. Investors cheered Moderna’s decision to put the case behind it and a lower settlement than feared. The company’s shares rose in Wednesday trading.

Today&rsquo;s biggest winners and losers in the stock market.
On this episode of Stock Movers:
-Abercrombie &amp; Fitch (ANF) shares fell as much as 9.4%, the most intraday since Jan. 12, after the apparel retailer&rsquo;s forecast for first quarter net sales growth and profits trailed the consensus estimates. Fourth quarter comparable sales performance also missed expectations, with Hollister growth failing to reach expectations.
-Wix (WIX) shares rose as analysts pointed to signs of positive momentum, especially at its AI-powered platform Base44. However, they also noted that the results were mixed and flag that investments being made by the company will weigh on margins.
- Moderna (MRNA) agreed to pay $950 million to settle litigation related to the delivery technology behind its Covid shot, removing a looming financial risk for the struggling vaccine maker. The company has settled all litigation worldwide with Arbutus Biopharma Corp. and Genevant Sciences GmbH over its existing and future vaccines, with no future royalties owed. Investors cheered Moderna&rsquo;s decision to put the case behind it and a lower settlement than feared. The company&rsquo;s shares rose in Wednesday trading.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Abercrombie & Fitch Slides, Wix Rises, Moderna Rallies

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/dcd91a8f-66b6-4dfe-b360-b403015ae288/transcript